Literature DB >> 9914476

Slow-binding and competitive inhibition of 8-amino-7-oxopelargonate synthase, a pyridoxal-5'-phosphate-dependent enzyme involved in biotin biosynthesis, by substrate and intermediate analogs. Kinetic and binding studies.

O Ploux1, O Breyne, S Carillon, A Marquet.   

Abstract

8-Amino-7-oxopelargonate synthase catalyzes the first committed step of biotin biosynthesis in micro-organisms and plants. Because inhibitors of this pathway might lead to antibacterials or herbicides, we have undertaken an inhibition study on 8-amino-7-oxopelargonate synthase using six different compounds. d-Alanine, the enantiomer of the substrate of this pyridoxal-5'-phosphate-dependent enzyme was found to be a competitive inhibitor with respect to l-alanine with a Ki of 0.59 mm. The fact that this inhibition constant was four times lower than the Km for l-alanine was interpreted as the consequence of the inversion-retention stereochemistry of the catalyzed reaction. Schiff base formation between l or d-alanine and pyridoxal-5'-phosphate, in the active site of the enzyme, was studied using ultraviolet/visible spectroscopy. It was found that l and d-alanine form an external aldimine with equilibrium constants K = 4.1 mm and K = 37.8 mm, respectively. However, the equilibrium constant for d-alanine aldimine formation dramatically decreased to 1.3 mm in the presence of saturating concentration of pimeloyl-CoA, the second substrate. This result strongly suggests that the binding of pimeloyl-CoA induces a conformational change in the active site, and we propose that this new topology is complementary to d-alanine and to the putative reaction intermediate since they both have the same configuration. (+/-)-8-Amino-7-oxo-8-phosphonononaoic acid (1), the phosphonate derivative of the intermediate formed during the reaction, was our most potent inhibitor with a Ki of 7 microm. This compound behaved as a reversible slow-binding inhibitor, competitive with respect to l-alanine. Kinetic investigation showed that this slow process was best described by a one-step mechanism (mechanism A) with the following rate constants: k1 = 0.27 x 103 m-1.s-1, k2 = 1.8 s-1 and half-life for dissociation t1/2 = 6.3 min. The binding of compound 1 to the enzyme was also studied using ultraviolet/visible spectroscopy, and the data were consistent with the kinetic data (K = 4.2 microm). Among the other compounds tested, two potential transition state analogs, 4-carboxybutyl(1-amino-1-carboxyethyl)phosphonate (4) and 2-amino-3-hydroxy-2-methylnonadioic acid (5) were found to be competitive inhibitors with respect to l-alanine with Ki of 68 microm and 80 microm, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9914476     DOI: 10.1046/j.1432-1327.1999.00006.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  Biotin synthesis in plants. The first committed step of the pathway is catalyzed by a cytosolic 7-keto-8-aminopelargonic acid synthase.

Authors:  Violaine Pinon; Stéphane Ravanel; Roland Douce; Claude Alban
Journal:  Plant Physiol       Date:  2005-11-18       Impact factor: 8.340

2.  Investigation of the slow inhibition of almond beta-glucosidase and yeast isomaltase by 1-azasugar inhibitors: evidence for the 'direct binding' model.

Authors:  A Lohse; T Hardlei; A Jensen; I W Plesner; M Bols
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

3.  Transient state kinetic investigation of 5-aminolevulinate synthase reaction mechanism.

Authors:  Junshun Zhang; Gloria C Ferreira
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

4.  Mimicking the human environment in mice reveals that inhibiting biotin biosynthesis is effective against antibiotic-resistant pathogens.

Authors:  Lindsey A Carfrae; Craig R MacNair; Christopher M Brown; Caressa N Tsai; Brent S Weber; Soumaya Zlitni; Vishwas N Rao; Joshua Chun; Murray S Junop; Brian K Coombes; Eric D Brown
Journal:  Nat Microbiol       Date:  2019-10-28       Impact factor: 30.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.